ArticleJournal of asthma and allergy2026
Development and Internal Evaluation of a Clinical-Physiological Model for Predicting Methacholine-Defined Airway Hyperresponsiveness in Children Aged 0-3 Years.
Article in Journal of asthma and allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Assessing airway hyperresponsiveness (AHR) in children aged 0-3 years is crucial for early asthma diagnosis but is clinically challenging due to the safety risks and technical complexity of the methacholine challenge test (MCT). This study aimed to develop and internally evaluate a non-invasive, multidimensional nomogram to predict current methacholine-defined AHR in children aged 0-3 years with suspected asthma. Patients and Methods: We conducted a retrospective cohort study of children aged 0-3 years with suspected asthma who underwent same-day tidal breathing pulmonary function testing, fractional exhaled nitric oxide (FeNO) measurement, and MCT. Clinical symptoms and atopic history were extracted from electronic medical records. Multivariable logistic regression was used to identify independent predictors of AHR. The model was internally evaluated using a single 70/30 random split into training and evaluation cohorts. Model performance was assessed by discrimination, calibration, and decision curve analysis and compared with machine-learning approaches. Results: Seven independent predictors were identified: family history of asthma (OR = 3.90), presence of wheeze (OR = 3.85), history of allergy (OR = 2.34), history of rhinitis (OR = 1.69), FeNO (OR = 1.03), age (OR = 0.96), and TPTEF/TE (OR = 0.97). The model achieved an AUC of 0.81 (95% CI: 0.77-0.85) in the training cohort and 0.76 (95% CI: 0.69-0.84) in the evaluation cohort. At the optimal cutoff, the PPV and NPV were 0.89 and 0.39, respectively, in the evaluation cohort. SHAP analysis identified family history of asthma, wheeze, and FeNO as the most influential predictors. Conclusion: We developed a clinical-physiological nomogram for predicting methacholine-defined AHR in children aged 0-3 years. It serves as an adjunctive tool in tertiary care to identify patients with a high probability of AHR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.